ReviewThe Urologic clinics of North America2018
Imaging of Solid Renal Masses.
Review in The Urologic clinics of North America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 59 citations in OpenAlex.
- CT-Based Radiomics in the Characterization of Solid Renal Tumors: A Systematic Review.Cancers · 2026Review
- A novel pathogenic variant in folliculin identified in a Chinese family with BHD syndrome.BMC medical genomics · 2026Article
- K-Means Clustering of HyperpolarisedCancers · 2025Article
- Metabolic parameters analysis ofAmerican journal of nuclear medicine and molecular imaging · 2025Article
- [Small renal mass: which criteria are decisive for a tumor board?]Urologie (Heidelberg, Germany) · 2024Review
- Frequency of benign tumors after partial nephrectomy and the association between malignant tumor findings and preoperative clinical parameters.BMC urology · 2024Article
- Contrast-Enhanced Ultrasound in the Diagnosis of Solid Renal Lesions.Journal of clinical medicine · 2024Review
- The kidney imaging surveillance scoring system (KISSS): using qualitative MRI features to predict growth rate of renal tumors in patients with von-Hippel Lindau (VHL) syndrome.Abdominal radiology (New York) · 2024Article
- Differentiation between renal epithelioid angiomyolipoma and clear cell renal cell carcinoma using clear cell likelihood score.Abdominal radiology (New York) · 2023Article
- The success rate of small renal mass core needle biopsy and its impact on lowering benign resection rate.BMC urology · 2023Article
- Review
- Mucinous tubular and spindle cell carcinomas of the kidney (MTSCC-Ks): CT and MR imaging characteristics.Japanese journal of radiology · 2022Article
- Diagnosis and Treatment of Small Renal Masses: Where Do We Stand?Current urology reports · 2022Review
- [European journal of nuclear medicine and molecular imaging · 2021Article
- Inflammatory pseudotumor of Castleman disease and IgG4-related disease masquerading as kidney malignancy.Diagnostic pathology · 2021Article
- Imaging Characterization of Renal Masses.Medicina (Kaunas, Lithuania) · 2021Review
- Article
- Active surveillance of small renal masses.Insights into imaging · 2020Review
- Applications of radiomics in genitourinary tumors.American journal of cancer research · 2020Review
- Identification of a Novel Pathogenic Folliculin Variant in a Chinese Family With Birt-Hogg-Dubé Syndrome (Hornstein-Knickenberg Syndrome).Frontiers in genetics · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
Abstract
The increase in serendipitous detection of solid renal masses on imaging has not resulted in a reduction in mortality from renal cell carcinoma. Consequently, efforts for improved lesion characterization have been pursued and incorporated into management algorithms for distinguishing clinically significant tumors from those with favorable histology or benign conditions. Although diagnostic imaging strategies have evolved for optimized lesion detection, distinction between benign tumors and both indolent and aggressive malignant neoplasms remain an important diagnostic challenge. Recent advances in cross-sectional imaging have expanded the role of these tests in the noninvasive characterization of solid renal tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.